Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
28 06 2022
Historique:
received: 09 05 2022
revised: 17 06 2022
accepted: 23 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Pathogen-associated molecular patterns, including cytoplasmic DNA and double-strand (ds)RNA trigger the induction of interferon (IFN) and antiviral states protecting cells and organisms from pathogens. Here we discovered that the transfection of human airway cell lines or non-transformed fibroblasts with 24mer dsRNA mimicking the cellular micro-RNA (miR)29b-1* gives strong anti-viral effects against human adenovirus type 5 (AdV-C5), influenza A virus X31 (H3N2), and SARS-CoV-2. These anti-viral effects required blunt-end complementary RNA strands and were not elicited by corresponding single-strand RNAs. dsRNA miR-29b-1* but not randomized miR-29b-1* mimics induced IFN-stimulated gene expression, and downregulated cell adhesion and cell cycle genes, as indicated by transcriptomics and IFN-I responsive Mx1-promoter activity assays. The inhibition of AdV-C5 infection with miR-29b-1* mimic depended on the IFN-alpha receptor 2 (IFNAR2) and the RNA-helicase retinoic acid-inducible gene I (RIG-I) but not cytoplasmic RNA sensors MDA5 and ZNFX1 or MyD88/TRIF adaptors. The antiviral effects of miR29b-1* were independent of a central AUAU-motif inducing dsRNA bending, as mimics with disrupted AUAU-motif were anti-viral in normal but not RIG-I knock-out (KO) or IFNAR2-KO cells. The screening of a library of scrambled short dsRNA sequences identified also anti-viral mimics functioning independently of RIG-I and IFNAR2, thus exemplifying the diverse anti-viral mechanisms of short blunt-end dsRNAs.

Identifiants

pubmed: 35891387
pii: v14071407
doi: 10.3390/v14071407
pmc: PMC9322957
pii:
doi:

Substances chimiques

Antiviral Agents 0
Interferon Type I 0
MicroRNAs 0
RNA, Double-Stranded 0
DEAD Box Protein 58 EC 3.6.4.13
DEAD-box RNA Helicases EC 3.6.4.13

Banques de données

ClinicalTrials.gov
['NCT02735824']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swiss National Science Foundation
ID : 31003A_179256 / 1
Pays : Switzerland
Organisme : Swiss National Science Foundation
ID : 51RT 0_126008
Pays : Switzerland

Références

Immunity. 2005 Aug;23(2):165-75
pubmed: 16111635
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
EMBO Rep. 2022 Feb 3;23(2):e54341
pubmed: 34914162
Nat Biotechnol. 2017 Apr;35(4):347-349
pubmed: 28263296
Mol Ther. 2012 May;20(5):948-53
pubmed: 22334017
Physiol Genomics. 2012 Feb 27;44(4):237-44
pubmed: 22214600
Nature. 2010 Feb 11;463(7282):818-22
pubmed: 20081832
J Virol. 2007 Oct;81(19):10540-9
pubmed: 17652395
J Cell Sci. 2020 Nov 9;134(5):
pubmed: 32917739
J Biol Chem. 2011 Feb 25;286(8):6108-16
pubmed: 21159780
Mol Ther. 2022 May 4;30(5):1850-1868
pubmed: 35189345
Nat Biotechnol. 2005 Apr;23(4):457-62
pubmed: 15778705
Cell Host Microbe. 2011 Aug 18;10(2):105-17
pubmed: 21843868
Nat Cell Biol. 2019 Nov;21(11):1346-1356
pubmed: 31685995
J Allergy Clin Immunol. 2021 Aug;148(2):381-393
pubmed: 33872655
Mol Cell. 2019 Oct 3;76(1):96-109.e9
pubmed: 31474572
BMC Genomics. 2014 Dec 22;15:1162
pubmed: 25534632
RNA. 2006 Oct;12(10):1790-3
pubmed: 16921069
Immunity. 2009 Jul 17;31(1):25-34
pubmed: 19576794
Front Mol Biosci. 2022 Apr 11;9:830161
pubmed: 35480881
Immunity. 2013 May 23;38(5):855-69
pubmed: 23706667
Nat Biotechnol. 2006 May;24(5):559-65
pubmed: 16648842
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17516-21
pubmed: 24101521
Cell Host Microbe. 2010 Jun 25;7(6):427-39
pubmed: 20542247
J Virol. 2013 Nov;87(22):12367-79
pubmed: 24027314
Nat Methods. 2006 Mar;3(3):199-204
pubmed: 16489337
J Med Virol. 2006 Jan;78(1):74-82
pubmed: 16299717
Nat Commun. 2017 Nov 27;8(1):1789
pubmed: 29176620
BMC Immunol. 2009 Jul 24;10:40
pubmed: 19630977
Cell Host Microbe. 2013 Mar 13;13(3):336-46
pubmed: 23498958
Cell Rep. 2019 Feb 19;26(8):2019-2027.e4
pubmed: 30784585
J Virol. 2019 Jun 28;93(14):
pubmed: 31043531
Front Genet. 2015 Dec 02;6:340
pubmed: 26697058
J Cell Physiol. 2012 Jun;227(6):2668-76
pubmed: 21898404
Biochem Pharmacol. 2021 Jan;183:114316
pubmed: 33152343
Microbes Infect. 2011 May;13(5):516-25
pubmed: 21276872
Mol Cell. 2017 Jul 20;67(2):214-227.e7
pubmed: 28625552
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4548-53
pubmed: 24616511
Cell Rep. 2019 Dec 17;29(12):3785-3795.e8
pubmed: 31851912
PLoS Pathog. 2018 May 21;14(5):e1007055
pubmed: 29782552
Q Rev Biophys. 2021 Jul 06;54:e8
pubmed: 34225835
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Virol. 2005 Aug;79(15):9556-65
pubmed: 16014917
Arch Virol. 2007;152(12):2137-57
pubmed: 17851732
Nucleic Acids Res. 2020 Dec 16;48(22):12917-12928
pubmed: 33245767
Microbiol Mol Biol Rev. 2004 Sep;68(3):432-52, table of contents
pubmed: 15353564
Cell. 2017 Jul 13;170(2):352-366.e13
pubmed: 28709002
Cell Death Dis. 2018 Feb 15;9(3):272
pubmed: 29449668
PLoS Comput Biol. 2013;9(9):e1003235
pubmed: 24068911
J Virol. 2015 Feb;89(3):1608-27
pubmed: 25410853
Nucleic Acids Res. 2022 Jan 11;50(1):333-349
pubmed: 34928377
Front Bioeng Biotechnol. 2022 Mar 02;10:801870
pubmed: 35309990
Mol Syst Biol. 2012 Apr 24;8:579
pubmed: 22531119
Mol Ther Nucleic Acids. 2019 Mar 1;14:509-519
pubmed: 30753994
Mol Microbiol. 2022 Apr 17;:
pubmed: 35434852
Cell. 1993 Nov 5;75(3):477-86
pubmed: 8221887
Nat Med. 2005 Mar;11(3):263-70
pubmed: 15723075
Cell Rep. 2012 Nov 29;2(5):1187-96
pubmed: 23142662
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
RNA. 2006 Jul;12(7):1179-87
pubmed: 16682560
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Mol Cell. 2008 Feb 29;29(4):428-40
pubmed: 18242112
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Viruses. 2021 Aug 09;13(8):
pubmed: 34452433
Nat Rev Genet. 2008 Feb;9(2):102-14
pubmed: 18197166
J Virol. 2015 Aug;89(16):8318-33
pubmed: 26041291
PLoS Pathog. 2021 Jul 28;17(7):e1009759
pubmed: 34320031
EMBO Rep. 2013 Sep;14(9):772-9
pubmed: 23897087
Annu Rev Virol. 2019 Sep 29;6(1):567-584
pubmed: 31283436
Methods Mol Biol. 2007;356:319-50
pubmed: 16988414
Virology. 2011 Mar 15;411(2):325-43
pubmed: 21277611
Mol Ther Oncolytics. 2018 Dec 31;12:173-194
pubmed: 30788428
Annu Rev Immunol. 2019 Apr 26;37:349-375
pubmed: 30673536
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52):
pubmed: 34903581
Annu Rev Immunol. 2001;19:623-55
pubmed: 11244049
Viruses. 2011 Jul;3(7):1112-30
pubmed: 21994773
Exp Biol Med (Maywood). 2016 Feb;241(4):409-20
pubmed: 26518627
PLoS One. 2013;8(1):e55214
pubmed: 23358900
Cell Mol Immunol. 2021 Mar;18(3):539-555
pubmed: 33462384
Nature. 2020 Jun;582(7813):561-565
pubmed: 32365353
J Virol. 2004 Dec;78(23):12868-76
pubmed: 15542639
J Biol Chem. 2000 Jun 16;275(24):18271-8
pubmed: 10751399
J Allergy Clin Immunol. 2019 Nov;144(5):1441-1445.e17
pubmed: 31419545
PLoS One. 2013 Jul 12;8(7):e68450
pubmed: 23874633
Nat Microbiol. 2021 Oct;6(10):1319-1333
pubmed: 34556855
Nat Rev Drug Discov. 2007 Dec;6(12):975-90
pubmed: 18049472
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832
Curr Res Virol Sci. 2022;3:100019
pubmed: 35072124
Mol Cell. 2022 Jan 6;82(1):30-43
pubmed: 34942118
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13830-5
pubmed: 20643939
Nature. 2007 Aug 16;448(7155):816-9
pubmed: 17653195
Cell Rep. 2021 Jan 12;34(2):108628
pubmed: 33440148
Nucleic Acids Res. 2010 Jan;38(3):750-63
pubmed: 19933264
Cell Host Microbe. 2015 Dec 9;18(6):723-35
pubmed: 26651948
Nature. 2007 May 10;447(7141):222-6
pubmed: 17495927
Sci Adv. 2018 Feb 21;4(2):e1701854
pubmed: 29492454
Front Genet. 2021 Jun 07;12:678994
pubmed: 34163530
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Nat Microbiol. 2019 Jul;4(7):1075-1087
pubmed: 31160826
Eur J Immunol. 2006 May;36(5):1222-30
pubmed: 16609928
Nat Rev Immunol. 2020 Sep;20(9):537-551
pubmed: 32203325
Mol Ther Nucleic Acids. 2015 Sep 15;4:e252
pubmed: 26372022
J Mol Biol. 2022 Apr 15;434(7):167501
pubmed: 35183559

Auteurs

Abhilash Kannan (A)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
Neurimmune AG, Wagistrasse 18, 8952 Schlieren, Switzerland.

Maarit Suomalainen (M)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.

Romain Volle (R)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.

Michael Bauer (M)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Marco Amsler (M)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.

Hung V Trinh (HV)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
Genezen, 9900 Westpoint Dr, Suite 128, Indianapolis, IN 46256, USA.

Stefano Vavassori (S)

Division of Immunology, University Children's Hospital Zürich, 8032 Zürich, Switzerland.

Jana Pachlopnik Schmid (JP)

Division of Immunology, University Children's Hospital Zürich, 8032 Zürich, Switzerland.
Faculty of Medicine, University of Zürich, 8006 Zürich, Switzerland.

Guilherme Vilhena (G)

Departamento de Física Teórica de la Materia Condensada, Universidad Autónoma de Madrid, E-28049 Madrid, Spain.
Condensed Matter Physics Center (IFIMAC), Universidad Autónoma de Madrid, E-28049 Madrid, Spain.

Alberto Marín-González (A)

Department of Macromolecular Structures, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Cantoblanco, E-28049 Madrid, Spain.

Ruben Perez (R)

Departamento de Física Teórica de la Materia Condensada, Universidad Autónoma de Madrid, E-28049 Madrid, Spain.
Condensed Matter Physics Center (IFIMAC), Universidad Autónoma de Madrid, E-28049 Madrid, Spain.

Andrea Franceschini (A)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, 20139 Milano, Italy.
Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.

Christian von Mering (CV)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.

Silvio Hemmi (S)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.

Urs F Greber (UF)

Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH